Aadi Stock Based Compensation vs End Period Cash Flow Analysis
AADI Stock | USD 2.36 0.05 2.07% |
Aadi Bioscience financial indicator trend analysis is way more than just evaluating Aadi Bioscience prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Aadi Bioscience is a good investment. Please check the relationship between Aadi Bioscience Stock Based Compensation and its End Period Cash Flow accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aadi Bioscience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. For more detail on how to invest in Aadi Stock please use our How to Invest in Aadi Bioscience guide.
Stock Based Compensation vs End Period Cash Flow
Stock Based Compensation vs End Period Cash Flow Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Aadi Bioscience Stock Based Compensation account and End Period Cash Flow. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Aadi Bioscience's Stock Based Compensation and End Period Cash Flow is 0.44. Overlapping area represents the amount of variation of Stock Based Compensation that can explain the historical movement of End Period Cash Flow in the same time period over historical financial statements of Aadi Bioscience, assuming nothing else is changed. The correlation between historical values of Aadi Bioscience's Stock Based Compensation and End Period Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Stock Based Compensation of Aadi Bioscience are associated (or correlated) with its End Period Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when End Period Cash Flow has no effect on the direction of Stock Based Compensation i.e., Aadi Bioscience's Stock Based Compensation and End Period Cash Flow go up and down completely randomly.
Correlation Coefficient | 0.44 |
Relationship Direction | Positive |
Relationship Strength | Weak |
Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.End Period Cash Flow
Most indicators from Aadi Bioscience's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Aadi Bioscience current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aadi Bioscience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. For more detail on how to invest in Aadi Stock please use our How to Invest in Aadi Bioscience guide.As of now, Aadi Bioscience's Enterprise Value Multiple is increasing as compared to previous years.
2021 | 2022 | 2023 | 2024 (projected) | Reconciled Depreciation | 105K | 159K | 171K | 122.1K | Interest Income | 13K | 2.4M | 6.5M | 6.8M |
Aadi Bioscience fundamental ratios Correlations
Click cells to compare fundamentals
Aadi Bioscience Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Aadi Bioscience fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 39.9M | 18.8M | 157.9M | 184.2M | 132.4M | 139.0M | |
Total Stockholder Equity | 36.5M | (12.4M) | 136.4M | 158.4M | 105.2M | 110.5M | |
Net Debt | (38.4M) | 5.8M | (148.4M) | (37.4M) | (61.6M) | (58.5M) | |
Retained Earnings | (142.2M) | (32.6M) | (142.7M) | (203.2M) | (269.0M) | (255.5M) | |
Cash | 38.5M | 4.5M | 149.0M | 39.0M | 62.9M | 66.0M | |
Cash And Short Term Investments | 38.5M | 4.5M | 149.0M | 172.6M | 108.8M | 114.3M | |
Common Stock Shares Outstanding | 2.7M | 2.5M | 8.9M | 22.5M | 26.9M | 28.3M | |
Liabilities And Stockholders Equity | 39.9M | 18.8M | 157.9M | 184.2M | 132.4M | 139.0M | |
Other Stockholder Equity | 179.1M | 20.2M | 279.1M | 361.7M | 374.1M | 392.8M | |
Total Current Assets | 39.6M | 18.7M | 151.3M | 180.0M | 124.6M | 130.8M | |
Total Current Liabilities | 3.3M | 30.1M | 15.3M | 18.8M | 26.4M | 27.7M | |
Total Liab | 3.4M | 31.3M | 21.5M | 25.9M | 27.2M | 28.6M | |
Other Current Liab | 2.8M | 99K | 8.7M | 14.5M | 20.1M | 21.1M | |
Accounts Payable | 439.8K | 2.4M | 6.4M | 3.5M | 5.9M | 6.2M | |
Other Current Assets | 1.0M | 81K | 4.6M | 3.7M | 3.8M | 4.0M | |
Non Current Assets Total | 366.3K | 140K | 6.6M | 4.2M | 7.8M | 8.2M | |
Non Currrent Assets Other | 40.0K | (140K) | 2.2M | 2.1M | 1.9M | 2.0M | |
Property Plant And Equipment Net | 326.3K | 140K | 614K | 2.0M | 6.0M | 6.3M | |
Accumulated Other Comprehensive Income | (335.8K) | (311.1K) | (328.9K) | (115K) | 27K | 28.4K | |
Property Plant And Equipment Gross | 326.3K | 185.6K | 614K | 2.0M | 6.2M | 6.6M | |
Net Tangible Assets | (9.1M) | 43.1M | 132.6M | 158.4M | 182.1M | 191.2M | |
Property Plant Equipment | 316.0K | 121.7K | 57K | 2.0M | 2.3M | 2.5M |
Currently Active Assets on Macroaxis
When determining whether Aadi Bioscience offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aadi Bioscience's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aadi Bioscience Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aadi Bioscience Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aadi Bioscience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. For more detail on how to invest in Aadi Stock please use our How to Invest in Aadi Bioscience guide.You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aadi Bioscience. If investors know Aadi will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aadi Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.28) | Revenue Per Share 0.929 | Quarterly Revenue Growth 0.21 | Return On Assets (0.35) | Return On Equity (0.66) |
The market value of Aadi Bioscience is measured differently than its book value, which is the value of Aadi that is recorded on the company's balance sheet. Investors also form their own opinion of Aadi Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Aadi Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aadi Bioscience's market value can be influenced by many factors that don't directly affect Aadi Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aadi Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aadi Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aadi Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.